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Vascular injuries resulting from blunt trauma are uncommon in the pediatric age. In children, there are particular factors
that should be taken into account when vascular traumatic lesions are treated: small vessel size or vessel spasm, a higher
risk of infection, a tendency for restenosis, and rapid body growth. The endovascular procedure is a minimally invasive,
quick technique that restores blood flow immediately. The stent’s fate is the Achille’s heel of this technique; this is the
reason why a careful follow-up and further studies are required. (J Vasc Surg 2006;44:201-5.)Vascular injuries resulting from blunt trauma are rare in
children, and for this reason the best surgical treatment is
still unknown. Direct arterial repair with or without end-
to-end anastomosis, interposition of an autogenous re-
versed saphenous vein graft, and ligation have been re-
ported. A literature search did not yield any reports of
endovascular procedures to date. We describe herein a case
of femoropopliteal blunt trauma in a 13-year-old boy, who
was treated by endovascular stenting and who has been
followed up so far for 12 months.
CASE REPORT
A 13-year-old white boy (height, 135 cm; weight, 45 kg) fell
on a water tap while running in his home garden. After 3 hours he
was admitted to our vascular division with pain localized to the left
leg.
Physical examination showed pallor of the foot, and the leg
was cold from the distal third of the thigh. The femoral pulse was
present, but the popliteal and pedal pulses were absent. He also had
a huge posttraumatic hematoma of the thigh, and laboratory data
showed the loss of 1 point of hemoglobin. The child was immedi-
ately submitted to an echo color Doppler (ECD) examination,
which demonstrated occlusion of the distal superficial femoral
artery (SFA).
After 2 hours from admission, despite the administration of
medical and anticoagulation therapy with heparin, his clinical
symptoms had worsened. The patient was taken to the operating
room, where angiography confirmed the occlusion of the distal
SFA and showed the absence of the anterior tibial artery. The
angiogram also demonstrated a short artery occlusion, which sug-
gested the need for arterial stenting (Fig 1). The rationale for
choosing stenting vs a direct vascular reconstruction was based on
the arterial caliber (approximately 4 mm) and the size of the great
saphenous vein (approximately 2 mm) at the ECD, which led to
the decision to defer further surgery until the child was older and
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An endovascular approach was decided upon, therefore, and a
2-cm exposure of the left common femoral artery, followed by
catheterization via an antegrade approach, was performed. After
systemic anticoagulation therapy with 5000U of heparin, a Jostent
(5.0  20-mm nitinol stent; Jomed) was implanted in the distal
superfacial femoral artery.
The patient was discharged 4 days later with palpable pedal
pulses and a prescription for oral therapy with ticlopidine 250 mg
twice a day. Physical and ECD examination, performed every 3
months for 1 year, showed the presence of distal pulses, the patency
of the stent without any sign of restenosis, and a normal waveform.
The ankle-brachial index was always greater than 1 (Fig 2). At 12
months, there was also no difference in length between the two
legs, although the child grew 10 cm.
DISCUSSION
Vascular injuries in infants and children are rare, ac-
counting for approximately 1% of pediatric trauma admis-
sions in one multicenter experience.1 Age, sex, behavior,
and environment are the principal factors related to child-
hood injuries. Male children younger than 18 years of age
have higher injury rates as a result of their more aggressive
behavior and exposure to contact sports. In the infant and
toddler age group, falls are a common cause of severe
injuries, whereas bicycle-related mishaps are the main cause
of injury among older children and adolescents. Moreover,
as in our case, most significant injuries happen at home—
usually considered the most safe and comfortable place for
children. No less important are iatrogenic injuries, which
are increasing together with the adoption of minimally
invasive techniques.2-6
Vascular lesions require early diagnosis and treatment
to prevent severe complications. A lesion of a major artery
of the limb, if not rapidly identified, may produce pro-
longed ischemia, leading to gangrene, compartment syn-
drome, and Volkmann contractures, with ensuing long-
term disability and growth retardation of the limb. In
addition, when not combined with bone injuries, a vascular
lesion can often go undiagnosed, and more than 6 hours’
delay in diagnosis could compromise the limb’s viability.1,7
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differential diagnosis with thrombosis but has up to now
been confined to cases of catheterization of small children
with cardiac diseases and has been secondary to irritant
stimulus of the catheter against the endothelium. In cases
of thrombosis, there is evidence that adequate fibrinolytic
treatment could reopen segments of freshly thrombosed
arteries and veins. In this case, we did not consider the use
of thrombolytics because of the presence of a huge post-
traumatic hematoma of the thigh and the loss of 1 point of
hemoglobin.
The physical examination should always be associated
with an ECD, and according to our experience and in view
of the medicolegal implications, angiography should be
performed in all difficult cases and when an operative
procedure has to be planned. It should be performed in the
operating room for faster performance, if necessary, of
either endovascular or open procedures.
In older children or adults, a different approach is
usually required. In the pediatric population, there are
particular factors that should be taken into account when
vascular traumatic lesions are treated: small vessel size or
vessel spasm, a higher risk of infection, a tendency for
restenosis,5,8 and rapid body growth.
Depending on the anatomic location of the injury,
there may be differences between the incidence of arterial
ischemia in children and adults. In fact, peripheral vascular
injuries, which may result in limb loss in adults, rarely do so
in infants and children because there is a rapid development
of collateral circulation, which allows limb preservation
without surgical intervention, even if this collateral circula-
tion is not always adequate to ensure normal limb growth
patterns. Conversely, in blunt trauma involving the popli-
distal superficial femoral artery and the absence of the
osis with distal embolization.Fig 1. Angiographic pictures show a 2-cm occlusion of theFig 2. The echo color Doppler examination showed patency ofteal artery, if the repair is delayed by more than 6 hours, it
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amputation, as it does in adults.9
The importance and difficulty of ensuring normal limb
growth patterns have aroused some controversy with re-
gard to the indications for surgery. In 1983, Flamingan et
al10 reported a 23% incidence of lower limb length discrep-
ancy in patients who did not undergo surgical intervention,
vs 9% when the injuries were treated aggressively.
It should be also underlined that limb length discrep-
ancy depends greatly on the age when the injury occurs. If
it occurs before 13 or 14 years of age, when the growth
spurt usually takes place, children should be submitted to
surgical reconstruction to prevent limb shortening when-
ever possible. However, if the injury occurs at an older
age—15,16, or 17 years of age—more conservative treat-
ment can be performed provided that the ischemia is not
severe. Small children (6 years of age) with non–limb-
threatening ischemia can safely be followed up until they
reach 11 to 14 years of age and can then be revascularized
to prevent permanent limb shortening.11
In 1981, Smith and Green12 reported that good oper-
ative outcomes occurred less often in children younger than
2 years, and in 1982, Klein et al13 supported nonsurgical
management of iatrogenic vascular injuries in very small
children, because surgical therapy yielded disappointingly
poor results. The authors stressed the importance of close
observation, with the possible need for delayed surgical
reconstruction later in life.
In 2001, Cardneau et al14 published data on a series of
14 children with a mean age of 7.3 years (range, 2-14 years)
in whom a saphenous vein bypass was performed 5.7 years
after the ischemic event. A remarkable improvement was
obtained in five children with limb length discrepancy after
late revascularization.
Analysis of these data confirms that all these authors
agree that surgical reconstruction is indicated in all patients
except for the very young. In fact, however, the use of fine
microvascular reconstruction techniques under the micro-
scope has demonstrated that small vessels (1 mm in diam-
eter) can be successfully reconstructed by using fine 8-0 to
10-0 sutures.15 Of course, in very small children with
limb-threatening ischemia and in poor general condition,
thrombolytic agents should be considered as the initial
therapeutic approach. Nevertheless, the timing of surgery
in cases of chronic vascular insufficiency remains controver-
sial. Considering our experience with traumatic lesions at
the femoropopliteal level, we think that the presence of
acute ischemia with worsening clinical symptoms within a
period of 2 hours to a maximum of 5 hours should be
considered a proper indication for immediate surgical in-
tervention.
The type of conduit to use for the bypass has also been
debated. The type of conduit recommended is the saphe-
nous vein, with Dacron (DuPont, Wilmington, Del) or
expanded polytetrafluoroethylene conduits reserved for
older children.16,17
The endovascular procedure is a minimally invasive,
quick technique that allows immediate restoration of theblood flow, thus avoiding a femoropopliteal bypass below
the knee and its possible complications. Moreover, open
revascularization can be performed when the endovascular
technique fails. The antegrade approach, with exposure of
2 cm of common femoral artery, is helpful when a femo-
ropopliteal bypass has to be performed, and it avoids all
the complications related to percutaneous catheteriza-
tion.2-5,10,12 These complications were amply explored in
a recent work by Lin et al,6 who described a 2% incidence of
complications such as pseudoaneurysm, arteriovenous fis-
tula, hematoma/hemorrhage, and acute and chronic isch-
emia in the last 15 years at their institution.
The durability and the patency of the stent are the
Achilles heels of this technique. Nowadays, a wide range of
stents are available for the SFA. Recent reports of SFA
stents using self-expanding nitinol designs have shown
improved 1- to 2-year primary and secondary patency, but
the secondary reintervention rates for occlusion or in-stent
restenosis remain high (20%-30% at 1 year).18
Nevertheless, these results seem to be superior to those
reported with balloon-expandable and first-generation self-
expanding stents.19 In the SIROCCO (SIROlimus-Coated
Cordis SMART nitinol self-expanding stent for the treat-
ment of Obstructing superficial femoral artery disease) trial,
the only evaluation of drug-eluting stent performance in
the SFA, no significant 6- to 12-month SFA in-stent reste-
nosis was reported with sirolimus-coated stents in phase I
and II studies.20
Covered polytetrafluoroethylene stents (Haemobahn,
Gore Medical Products, Flagstaff, Ariz) seem to yield re-
sults comparable to those with surgical prosthetic by-
pass.16,21 It should, however, be underlined that they were
tested in relatively small series of patients. A comparative
study between endovascular placement of the stent graft
and surgical bypass would help to provide evidence sup-
porting the use of this technique.
Stent fracture has also been reported, and the cause of
this strut fracture is still under investigation but seems to be
related to mechanical stress and metal fatigue of the stent as
a result of the biomechanical forces affecting the SFA. In
the SIROCCO trial, strut fracture was noted in both the
control arm and the drug-eluting stent arm (18.2%). It also
seems to be related to long stented segments with multiple
overlapping stents; this may increase the axial stiffness of
the stented segment.10
Mechanical stress also causes stent dislocations, which
may be avoided by using a very flexible endovascular device
with a tissue-friendly inner surface that promotes rapid
stent endothelialization to counter the biological effects of
motion and microtrauma.17 Preservation of all muscular
perforating side branches, which will be occluded by the
use of a covered stent, was one of the goals in designing the
spiral covered aSpire stent (Vascular Architects, San Jose,
Calif). This kind of device also responds to the flexibility
requirements within the SFA to eliminate recoil, compres-
sion, or both.
Infection of the stent and consequent aneurysmal de-
generation of the SFA is a rare complication, first described
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investigated as a means of achieving temporary mechanical
vessel support rather than long-term implantation. They
should also remove a potential trigger for late restenosis. In
this study, even if limited by the small number of patients,
the primary clinical patency after 3 months and the limb
salvage rates suggest a promising performance even in the
treatment of below-knee lesions in critical limb ischemia
patients.23
In our case, the stent was patent at 12 months, without
any sign of restenosis or lower limb discrepancy, although the
child grew 10 cm in 1 year. We think that in these kinds of
patients, the patencymight be guaranteed because the arteries
are normal and not atherosclerotic, the runin and the runoff
are good, and the endothelium function is maintained.
In-stent restenosis is the result of a healing process that
induces neointimal hyperplasia through mechanisms that are
still not understood. Results in animal studies in which stents
were implanted into normal coronary arteries demonstrate
that they could not be compared with those obtained in
atherosclerotic patients with endothelial dysfunction. The in-
hibitory effect of endothelium on vascular smooth cell prolif-
eration has long been recognized, and a large number of in
vitro or in vivo studies addressing the antiproliferative action
of endothelium-derived factors have been published.24 In our
case, we may conclude that the endothelial function of the
child was not altered, as it is in atherosclerotic patients or in
patients with atherosclerotic risk factors. This may play an
important role in preventing restenosis, but more evidence is
needed to confirm this hypothesis.However, the stent’s fate is
unknown, and for this reason careful follow-up at 5 to 10 years
after vascular reconstruction is required. Conversely, growth
and a tendency toward restenosis may lead to stent occlusion,
but this could also be asymptomatic, bearing in mind the
strong tendency to create collateral circulation in children.
We are currently monitoring our patient every 3 months
because we know that the stent will not expand more than 5
mm, whereas the SFA caliber is approximately 6 mm in an
adult. Moreover, if the radial expansion of the stent will not
accommodate to that of the artery and the patient experiences
a symptomatic occlusion of the stent (acute ischemia, claudi-
cation, and lower limb discrepancy), we plan to perform a new
endovascular approach if feasible; otherwise, we will apply a
saphenous vein interposition graft.
Biodegradable stents may be a solution to stent-related
problems, but they are still under investigation.23 At the
moment, close follow-up with physical and ECD examina-
tion is all that is required.
In conclusion, we consider that treating blunt femoral
trauma by stenting is a safe and effective option in children,
considering that after 1 year the child we operated on is
clinically normalwith palpable pedal pulses. The stent is patent
with no sign of restenosis, ECD examination shows a normal
waveform, and the ankle-brachial index is greater than 1.
Moreover, stenting could also be considered a bridge proce-
dure to delay open surgery in smaller children, in whom a
traditional operation may well be more successful when thechild is older and, hence, the arteries and veins to be used in
the reconstruction are larger.
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